Yan Leyfman, Medical Oncologist, Co-Founder and Executive Director of MedNews Week, shared American Society of Clinical Oncology (ASCO) post on LinkedIn, adding:
“Honored to be selected as a Featured Voice for ASCO Breakthrough 2026.
ASCO Breakthrough represents one of the premier global forums for advancing cancer research, bringing together investigators, clinicians, patient advocates, and innovators united by a shared commitment to improving outcomes for patients worldwide. I am excited not only to share insights from the meeting, but also to present our team’s research and contribute to conversations that will help shape the future of oncology.
This year’s meeting comes at a remarkable moment in cancer medicine. From immunotherapy and cellular therapy to artificial intelligence and precision oncology, we are witnessing a convergence of innovation with the potential to fundamentally transform how we diagnose, treat, and care for patients. I look forward to highlighting the discoveries, discussions, and perspectives that emerge from this unique gathering of global leaders.
What excites me most, however, is the opportunity to engage with colleagues from around the world who share a common purpose: pushing the boundaries of science while never losing sight of the patients and families we serve. Some of the most impactful advances begin with a question, a conversation, or a new collaboration.
Meetings such as ASCO Breakthrough provide a unique opportunity to bring together diverse perspectives, challenge conventional thinking, and accelerate progress across our field.
I am grateful to ASCO for this opportunity and look forward to engaging with the global oncology community in Singapore, sharing the latest advances from the meeting, and helping amplify the voices and discoveries that are driving the next era of cancer research and patient care.
See you at ASCOBT26.”
Quoting ASCO’s post:
“We’re excited to announce the 2026 ASCO Breakthrough Featured Voices! Follow them before, during, and after the meeting to get their expert insights on how the latest global oncology research findings connect to the unique clinical challenges and patient populations of the Asia-Pacific region.
Registration for in person or online attendance is still open.”
Other articles featuring Yan Leyfman and ASCO on OncoDaily.